PREDICTORS OF SEPSIS IN PATIENTS WITH URGENT CONDITIONS
https://doi.org/10.23934/2223-9022-2017-6-1-13-19
Abstract
Background. Given that the imbalance in pro- and anti-inflammatory cytokines plays an important role in the pathogenesis of sepsis, estimation of its prognostic value in patients in the early stages from the disease onset or injury is of concern.
Aim of study. To study changes in concentrations of biomarkers for inflammation on day 1–2 in patients with a high risk for sepsis.
Materials and methods. On day 1-2 from the admission, blood tests were performed in 48 patients with a high risk of sepsis: 9 — with mediastinitis, 6 — with widespread purulent peritonitis, 24 — with severe concomitant injury, 9 — with acute destructive pancreatitis. Sepsis occurred in 28 patients of group 1. Group 2 consisted of 20 patients without sepsis. We investigated concentration of procalcitonin, C-reactive protein, interleukine-6 and -10, lipopolysaccharide-bindidng protein and soluble receptor for interleukine-2.
Result. Significant differences in concentrations of groups were identified on day 1-2 in CRP (P=0.00009), IL-2R (P=0.0005) LBP (P=0.00002) and IL-6 (P=0.0192).
Conclusion. Hyper LBP and CRP on the background of high IL-2R, IL-6, increase the risk of sepsis.
About the Authors
G. V. Bulava
N.V. Sklifosovsky research Institute for Emergency Medicine
Russian Federation
Moscow
Russian Federation
Moscow
M. V. Androsova
N.V. Sklifosovsky research Institute for Emergency Medicine
Russian Federation
Moscow
Russian Federation
Moscow
A. K. Shabanov
N.V. Sklifosovsky research Institute for Emergency Medicine
Russian Federation
Moscow
Russian Federation
Moscow
O. V. Nikitina
N.V. Sklifosovsky research Institute for Emergency Medicine
Russian Federation
Moscow
Russian Federation
Moscow
I. V. Alexandrova
N.V. Sklifosovsky research Institute for Emergency Medicine
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Savel’ev V.S., Gel’fand B.R., ed. Sepsis: classification, clinical-diagnostic concept and treatment. 3rd ed., ext. and rev. Moscow: Meditsinskoe informatsionnoe agentstvo Publ., 2013. 360 p. (In Russian).
2. Lewis D.H., Chan D.L., Pinheiro D., et al. The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory respons, and regulatory T сells. J Vet Intern Med. 2012; 26(3): 457–482. PMID: 22428780. DOI: 10.1111/j.1939-1676.2012.00905.x.
3. Antonelli M. Sepsis and septic shock: pro-inflammatory or anti-inflammatory state? J Chemother. 1999; 11(6): 536–540. PMID: 10678797. DOI: 10.1179/joc.1999.11.6.536.
4. Cavaillon J.M., Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res. 2006; 12(3): 151–170. PMID: 16719987. DOI: 10.1179/096805106X102246.
5. Marshall J.C., Reinhart K. Biomarkers of sepsis. Crit Care Med. 2009; 37(7): 2290–2298. PMID: 19487943 DOI: 10.1097/CCM.0b013e3181a02afc.
6. Kozlov V.K. Sepsis: etiology, immunopathogenesis, the concept of modern immunotherapy. Saint Petersburg: Dialekt Publ., 2006. 300 p. (In Russian).
7. Boomer J.S., To K., Chang K.C., et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011; 306(23): 2594–2605. PMID: 22187279. DOI: 10.1001/jama.2011.1829.
8. Petrov R.V. Immunology and immunogenetics. Moscow: Meditsina Publ., 1976. 336 p. (In Russian).
9. Reinhart K., Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin. 2011; 27(2): 253–263. PMID: 21440200. DOI: 10.1016/j.ccc.2011.01.002.
10. Hotchkiss R.S., Nicholson D.W. Apotosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol. 2006; 6(11): 813–822. PMID: 17039247. DOI: 10.1038/nri1943.
11. Gaini S., Koldkjaer O.G., Pedersen C., Pedersen S.S. Procalcitonin, lipopolysac charide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care. 2006; 10(2): R53. PMID: 16569262. DOI: 10.1186/cc4866.
12. Heper Y., Akalin E.H., Mistik R., et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis. 2006; 25(8): 481–491. PMID: 16896829. DOI: 10.1007/s10096-006-0168-1.
13. Lobo S.M., Lobo F.R., Bota D.P., et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003; 123(6): 2043–2049. PMID: 12796187.
14. Reinhart K., Bauer M., Riedemann N.C., Hartoga Ch.S. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012; 25(4): 609–634. PMID: 2303432. DOI: 10.1128/CMR.00016-12.
15. Dandona P., Nix D., Wilson M.F., et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrin Metab. 1994; 79(6): 1605–1608. PMID: 7989463. DOI: 10.1210/jcem.79.6.7989463.
16. Vel’kov V.V. Procalcitonin in the diagnosis of critical conditions. Laboratornaya meditsina. 2009; (10): 49–54. (In Russian).
17. Maier M., Wutzler S., Lehnert M., et al. Serum procalcitonin levels in patients with multiple injuries including visceral trauma. J Trauma. 2009; 66(1): 243–249. PMID: 19131834. DOI: 10.1097/TA.0b013e31817c966f.
18. Shabanov A.K., Bulava G.V., Kislukhina E.V., Khubutiya M.Sh. Criteria of high risk infection pulmonary complications in severe polytrauma patients. Anesteziologiya i reanimatologiya. 2015; (2): 16–20. (In Russian).
19. Claeys R., Vinken S., Spapen H., et al. Plasma procalcitonin and C-reactive protein in acuteseptic shock: clinical and biological correlates. Crit Care Med. 2002; 30(4): 757–762. PMID: 11940741.
20. Villar J., Perez-Mundez L., Espinosa E., et al. Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis. PLoS One. 2009; 4(8): e6818. PMID: 19718443. DOI: 10.1371/journal.pone.0006818.
21. Kellum J.A., Kong L., Fink M.P., et al. Understanding the inflammatory cytokine response in pneumonia and sepsis. Arch Intern Med. 2007; 167(15): 1655–1663. PMID: 17698689. DOI: 10.1001/archinte.167.15.1655.
22. Giannoudis P.V., Hildebrand F., Pape H.C. Inflammatory serum markers in patients with multiple trauma. Can they predict outcome? J Bone Joint Surg Br. 2004; 86(3): 313–323. PMID: 15125116.
23. Gusev E.Yu., Yurchenko L.N., Chereshnev V.A., et al. The variants of acute systemic inflammation evolution. Tsitokiny i vospalenie. 2008; (2): 9–17. (In Russian).
24. Kozlov V.K., Vinnitskiy L.I. Role of Immune System Dysfunction in the Pathogenesis of Sepsis: Diagnostic Potentialities. Obshchaya reanimatologiya. 2005; 1(4): 65–76. (In Russian).
25. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6): 1644–1655. PMID: 1303622.
26. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31(4): 1250–1256. PMID: 12682500.
27. Kahlke V., Schafmayer C., Schniewind B., et al. Are postoperative complications genetically determined by TNF-β Ncol gene polymorphism? Surgery. 2004; 135(4): 365–373. PMID: 15041959. DOI: 10.1016/j.surg.2003.08.012.
Review
For citations:
Bulava G.V., Androsova M.V., Shabanov A.K., Nikitina O.V., Alexandrova I.V. PREDICTORS OF SEPSIS IN PATIENTS WITH URGENT CONDITIONS. Russian Sklifosovsky Journal "Emergency Medical Care". 2017;6(1):13-19. (In Russ.) https://doi.org/10.23934/2223-9022-2017-6-1-13-19
Views:
3243
Email this article 